Expert Pitch
Johns Hopkins University

Experts Available to Discuss Improving Rapid Detection Of and Response to Viruses Before They Become Pandemics.

12-Feb-2020 1:55 PM EST, by Johns Hopkins University

Newswise — Scientists developing a rapid system for tackling outbreaks of avian influenza at their origins in Thailand are available to discuss their project and how it could potentially help improve responses to other pandemic threats such as coronavirus.

Rapid and reliable detection of local outbreaks of emerging viruses is critical for stopping them before they spread from nation to nation, as coronavirus has tragically demonstrated.

Researchers from the Johns Hopkins University Applied Physics Laboratory and Bloomberg School of Public Health have forged a collaborative partnership with Thailand and its Mahidol University to develop a sustainable avian influenza surveillance tool that can be administered at on-the-ground locations where humans interact with poultry.

“When the next avian influenza pandemic strikes, it will disproportionately impact vulnerable populations living in low- and middle-income countries – both in terms of death and economic devastation,” wrote the researchers, APL’s Anissa Elayadi and public health PhD candidate Anastasia Lambrou working with professor Christopher Heaney, in a project summary. “At special risk are those working in the poultry industry who will have frontline exposure to the pathogen.”

Detecting avian influenza in global hotspots such as Thailand “involves advanced laboratory capacity, trained professionals, and hours of transportation with associated potential loss of virus viability,” they wrote. Together with seven colleagues, the Hopkins researchers will collaborate with Thailand’s departments of public health, disease control, and livestock development to identify ways to refine diagnostic processes and procedures that can ultimately be replicated at other global hotspots.

The efforts come as the risk of pandemics continually grow because of increased global travel and economic integration, urbanization, and environment exploitation, research shows. As Lambrou knows firsthand, Thailand has been a leader in Southeast Asia at seeking to build a new infrastructure that incorporates new, portable technologies for testing and genome sequencing, and for rapidly transmitting results to decision makers.

Health workers who have the right tools cannot report results in a timely manner if they consistently lack reliable Wi-Fi, mobile connectivity, and electricity to power portable devices and laptops, she said.

“We want to identify the gaps and map them out,” Lambrou said.

The World Bank’s Disease Control Priorities report details the dangers of delayed detection. Delayed reporting of early SARS (Severe Acute Respiratory Syndrome) cases in the 2003 pandemic resulted in the World Health Organization compelling member states to establish stricter standards for detecting, reporting on, and responding to outbreaks.

Although the international community “has made progress” toward limiting emerging outbreaks since then, poorer nations lack resources to deploy effective methods. That has led to “significant gaps in global pandemic preparedness,” as demonstrated in the 2014 Ebola epidemic in West Africa, where timely detection systems were lacking. The result: “disproportionately higher mortality impact on low- and middle-income countries.”



Filters close

Showing results

1120 of 5809
Released: 10-Jun-2021 4:05 PM EDT
Study Identifies How COVID-19 Linked to Alzheimer’s Disease-like Cognitive Impairment
Cleveland Clinic

A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer’s disease-like dementia. The findings, published in Alzheimer's Research & Therapy, indicate an overlap between COVID-19 and brain changes common in Alzheimer’s, and may help inform risk management and therapeutic strategies for COVID-19-associated cognitive impairment.

Released: 10-Jun-2021 3:25 PM EDT
5 Leadership Strategies for Better Adapting in a Crisis
University of Maryland, Robert H. Smith School of Business

Maryland Smith management expert and futurist Oliver Schlake describes how companies can prepare for the next crisis as the economy gradually emerges from the COVID-19 pandemic.

7-Jun-2021 2:30 PM EDT
COVID-19 Creates Hearing, Balance Disorders, Aggravates Tinnitus Symptoms
Acoustical Society of America (ASA)

Evidence suggests auditory and vestibular effects should be added to the growing list of physiological impacts of COVID-19. During the 180th Meeting, Colleen Le Prell from the University of Texas at Dallas will talk about hearing and balance disorders associated with coronavirus infection and how pandemic-related stress and anxiety may aggravate tinnitus symptoms. Her presentation, "Hearing disorders secondary to infection with SARS-CoV-2," will take place Thursday, June 10.

Released: 10-Jun-2021 10:55 AM EDT
NCCN Cancer Experts Answer Questions about COVID-19 Vaccines
National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.

Newswise:Video Embedded doe-scientists-deploy-creativity-speed-to-disrupt-covid-19
VIDEO
Released: 10-Jun-2021 9:00 AM EDT
DOE scientists deploy creativity, speed to disrupt COVID-19
Oak Ridge National Laboratory

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.

Released: 10-Jun-2021 9:00 AM EDT
Warmer temperatures lessen COVID-19 spread, but control measures still needed
Imperial College London

New research shows transmission of the virus behind COVID-19 varies seasonally, but warmer conditions are not enough to prevent transmission.

8-Jun-2021 12:45 PM EDT
Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Mayo Clinic

Treating transplant patients with mild to moderate cases of COVID-19 with monoclonal antibodies is safe and helps prevent serious illness, according to a Mayo Clinic study recently published in Open Forum Infectious Diseases. These results are especially important because transplant patients who are infected with COVID-19 have a higher risk of severe illness and death.

4-Jun-2021 2:25 PM EDT
Study Examines COVID-19 Among Patients Receiving Home Dialysis
American Society of Nephrology (ASN)

• Patients with kidney failure who are undergoing dialysis—whether at dialysis clinics or at home—face a higher risk of developing COVID-19 and a higher risk of dying from the disease.

4-Jun-2021 2:30 PM EDT
Immune Responses After COVID-19 Vaccination in Kidney Transplant Recipients and Patients on Dialysis
American Society of Nephrology (ASN)

• A large majority of patients with kidney failure on dialysis—but not kidney transplant recipients—developed antibody responses to SARS-CoV-2 after COVID-19 vaccination. • Vaccination also led to strong T cell responses against the virus that causes COVID-19 in all patients on dialysis, and in nearly 58% of kidney transplant recipients.

Newswise: New treatment demonstrated for people with vaccine clots
8-Jun-2021 10:50 AM EDT
New treatment demonstrated for people with vaccine clots
McMaster University

The treatment’s effectiveness was described in a report describing three Canadian patients who received the AstraZeneca vaccine, and who subsequently developed VITT. Two suffered clotting in their legs and the third had clots blocking arteries and veins inside their brain.


Showing results

1120 of 5809

close
2.54848